AKTS
Aktis Oncology, Inc. Common stock
NASDAQ: AKTS · HEALTHCARE · BIOTECHNOLOGY
$18.75
+0.16% today
Updated 2026-04-30
Market cap
$1.03B
P/E ratio
—
P/S ratio
159.27x
EPS (TTM)
$-1.21
Dividend yield
—
52W range
$15 – $29
Volume
0.4M
Aktis Oncology, Inc. Common stock (AKTS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |